Skip to content

Discontinued — last reported Q4 '25

Free cash flow at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$546M
Stryker logo
StrykerSYK
$415M+227%
Medtronic logo
MedtronicMDT
$2.09B+0.8%
Medline, Inc.
 logo
Medline, Inc. MDLN
$316M-45.9%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
STERIS logo
STERISSTE

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%

Valuation

See full
Market cap$10.27B-50.6%
Enterprise value$8.48B-55.6%
P/S0.9×-1.0×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Calculated from Baxter International’s reported figures.

The official record: Baxter International’s 10-K, filed February 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Baxter International's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Baxter International's free cash flow?
Baxter International (BAX) reported free cash flow of $83M in Q4 2025.
How has Baxter International's free cash flow changed year-over-year?
Baxter International's free cash flow decreased by 42.1% year-over-year, from $143.25M to $83M.
What is the long-term trend for Baxter International's free cash flow?
Over 4 years (2021 to 2025), Baxter International's free cash flow has grown at a -31.8% compound annual growth rate (CAGR), from $1.53B to $332M.